Press release
T&T Scientific Launches the World’s Best Manufacturing Platform for Nanomedicine Genetic Therapeutics and RNA (mRNA) Vaccines
On Sep 27th, Nima Tamaddoni, the CEO at T&T Scientific announces its revolutionary manufacturing platform for Nanomedicine Genetic Therapeutics and RNA (mRNA) Vaccines such as COVID-19 vaccines.The Chief Executive Officer at T&T Scientific, Dr. Nima Tamaddoni, made this announcement live. He emphasized: "It is a true honor and pleasure to push the NanoSizer FLOW GMP to the finish line and launch it. We started this platform to help millions of people reaching lifesaving gene therapeutics and vaccines the fastest with the highest quality and lowest cost possible. Either you are a small company or a large pharmaceutical manufacturer, or a formulation company, this platform provides a reliable, low-cost, high quality, high throughput solution in a very high range (100mL-500L+) of operation for the cGMP manufacturing of therapeutics and vaccines nanomedicines. We believe this is truly, and precisely the best nanomedicine manufacturing technology in the market. The team at T&T Scientific is excited to contribute to saving lives by preventing and curing diseases with novel gene therapeutics and vaccines. This technology specifically and precisely adds value to the market to help the entire world access much-needed lifesaving disease prevention and treatments. Big thanks to our team and everyone involved in this technology that puts significant time and cares into getting to this point.". Some of the clear competitive advantages can be listed as below:
• No String Attached: Customers and clients do not pay licensing or royalty fees for purchasing
• Scalable in a Wide Range: It covers high scale processing with the smallest footprint unit from 100mL to 500L+ (Continuous and Batch Modes)
• Low Cost: Significantly Lower Cost
• High Quality: Low PDI and High Encapsulation Efficiency (EE%)
• Quality Control Options: Pressure and Flow Rate Measurement
• Small Footprint and Bench Top
• Post-processing Tangential Flow Filtration (TFF) and Sterile Filtration Compatible
Alex Aust, MS, MBA, the director of business development at T&T Scientific, then presented live the demonstration of the technology with mRNA LNP production, which can be seen at:
https://www.youtube.com/watch?v=XgPC-95Z24U
T&T Scientific's future effort is to complete this technology with whole downstream filtration, including tangential flow filtration and downstream sterile filtration into fill and finish technologies, all in a closed system. T&T also offers services for contract development and manufacturing services from preclinical to commercial manufacturing.
Contact Name: Nima Tamaddoni, Ph.D.,
Company name: T&T Scientific Corp.
- Email address: Nima@ttscientific.com
URL: www.ttscientific.com/flow
It is important to note that T&T technology comes with full quality validation and qualification packages for GMP operation, and no royalty or licensing is required for customers to pay at any time. Once the unit is purchased, it will be all yours. This is a clear and competitive advantage to help the world use these systems anywhere from small to large pharmaceutical laboratories and manufacturing lines to site fields in Africa. This system can be set up, qualified, and validated for much-needed manufacturing of lifesaving therapeutics and vaccines.
YouTube link: https://www.youtube.com/watch?v=XgPC-95Z24U
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release T&T Scientific Launches the World’s Best Manufacturing Platform for Nanomedicine Genetic Therapeutics and RNA (mRNA) Vaccines here
News-ID: 2414418 • Views: …
More Releases for Lipid
Key Trends Shaping the Future Lipid Market From 2025-2034: Advancements In Scala …
What industry-specific factors are fueling the growth of the lipid market?
The lipid market's expansion is projected to be fuelled by a growing demand for nutritional supplements. The increase in nutritional requirements resulting from a more active lifestyle or health condition is often met with supplementation. Lipid-based nutrient supplements - those where lipids supply the majority of the energy and also encompass protein, energy, essential fatty acids, and micronutrients - play…
Lipid-Nanoparticle Based Genomic Medicines Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Lipid-Nanoparticle Based Genomic Medicines Market - (By Type (Liposome-based Nanoparticles, Micelle-based Nanoparticles, Lipid-Coated Nanoparticles), By Application (Cancer Treatment, Infectious Diseases, Genetic Disorders, Cardiovascular Diseases, Others), By Therapeutic Payload (mRNA-based Therapeutics, siRNA-based Therapeutics, miRNA-based Therapeutics, Other Genomic Medicines), By End-User (Hospitals, Biopharmaceutical Companies, Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the…
Lipid Regulators Market Report 2024 - Lipid Regulators Market Trends And Growth
"The Business Research Company recently released a comprehensive report on the Global Lipid Regulators Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
Lipid Research: Creative Biolabs Launches Its Lipid-Based Delivery Solutions
Creative Biolabs, a leading biotechnology company, unveiled its latest solutions for developing lipid-based delivery systems last week.
New York, USA - April 18, 2024 - "Liposomes as excellent drug delivery vehicles continuously drive innovation in drug delivery development and open up new breakthroughs and possibilities. Building on this momentum, we have designed a suite of solutions for lipid-based delivery system development," said an expert from the Lipid Research Department, Creative Biolabs.
Image:…
Creative Biolabs: Unlocking Lipid Biology With Complete Lipid Analysis Solutions
Creative Biolabs, a pioneer in the field of biotechnology, is delighted to announce the launch of cutting-edge assay and analysis solutions tailored specifically for liposome drug delivery.
New York, USA - March 26, 2024 - Liposomes, versatile lipid-based structures, have emerged as promising carriers for drug delivery due to their biocompatibility, flexibility, and capacity to encapsulate a wide range of therapeutics. To ensure the successful development of lipid-based drug delivery systems,…
Lipid Nanoparticles (LNP) Market Growth Is Attributed To The Increasing Demand F …
According to Precision Business Insights (PBI) latest report, the Lipid Nanoparticles (LNP) Market size is expected to be worth USD 675.0 Million in 2022, growing at a 7.5% CAGR from 2022 to 2028. The growing demand for therapeutic drugs and vaccinations to combat viral illnesses like Ebola, influenza, HIV, and other viruses, together with the traditional vaccine approach's failure to find vaccines in time for a crisis, are all contributing…